Home / Business and Economy / Exor Eyes 2 Billion Euros From Major Stake Sales
Exor Eyes 2 Billion Euros From Major Stake Sales
24 Mar
Summary
- Exor anticipates 2 billion euros from four stake sales this year.
- Proceeds from sales will exceed 1.4 times the invested capital.
- Cash available for deployment now exceeds 3.5 billion euros.
Exor, the Agnelli family's investment firm, anticipates raising 2 billion euros (approximately $2.32 billion) in proceeds this year through the divestment of its stakes in four companies. These include truck and bus maker Iveco Group, media group GEDI, healthcare firm Lifenet, and investment vehicle Nuo.
The firm has finalized stake sale agreements, with the expected proceeds surpassing 1.4 times the invested capital. This strategic move has substantially increased Exor's cash reserves available for deployment, now exceeding 3.5 billion euros.
CEO John Elkann stated that this enhanced financial position allows Exor to pursue investments of a scale and ambition comparable to its acquisition of Philips. Exor's investment in the Dutch health technology group Philips began in 2023 and has since been increased.
Despite challenges at its largest holdings, including a writedown by Stellantis related to electric vehicle ambitions, Exor's net asset value per share experienced an 8% decline in 2025, contrasting with a 5% rise in the MSCI World Index.
